Philip Mathuis our CEO, pitched on the HealthTech Investor Summit.

We are proud to announce that our CSO Prof. Kevin Braeckmans is again on this year’s Clarivate list of highly cited researchers.

In the pursuit of refining adoptive T cell transfer, a critical facet of cell therapies, a recent study Ghent University delves into the application of Photothermal Electrospun Nanofibers (PEN) for intracellular delivery. This technique has proven efficient for activated T cells and now presents a…

Successful Grant Application! Trince received a VLAIO R&D grant to support activities for further developing its novel intracellular delivery technology towards clinical cell-based therapeutic applications.

Trince is included in the “Emerging technologies & companies in cell & gene therapy manufacturing” review in the Tools of tomorrow issue of Cell & Gene Therapy insights.

Together with Revatis, we successfully used our LumiPore transfection platform to deliver macromolecules into equine and human mesenchymal stem cells.

ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients.

The Advanced Therapies Congress is Europe’s largest commercial cell and gene therapy conference and exhibition.

With a focus on “Live functional imaging: From chemical synthesis of the probes to instrumentation”, this edition aims to bring together chemists, microscope builders and biologists developping tools to probe life.